Institutional Ownership
Cognition Therapeutics Inc
CUSIP 19243B102COMCGTXQ1 2026
13D / 13G Filings
10
Schedule 13D/13G on record
Beneficial Filers
4
Distinct reporting persons
Largest Stake
7.5%
Max % of class reported
Institutional Holders
72
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
10 filings · latest Sep 23, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Sep 23, 2025 | Bios Memory Spv I, LP | 13D/A | 6.9% | — | SEC |
| 2 | Feb 4, 2025 | Pathstone Family Office, LLC | 13G | — | — | SEC |
| 3 | Feb 7, 2024 | Hirschman Orin | 13G/A | 4.8% | 1.45M | SEC |
| 4 | Jan 19, 2024 | Pathstone Family Office, LLC | 13G | 7.5% | 2.21M | SEC |
| 5 | Nov 13, 2023 | Bios Memory Spv I, LP | 13D/A | 4.6% | 1.42M | SEC |
| 6 | Feb 15, 2023 | Hirschman Orin | 13G/A | 7.0% | 2.04M | SEC |
| 7 | Dec 5, 2022 | Bios Memory Spv I, LP | 13D/A | 5.9% | 1.42M | SEC |
| 8 | Nov 18, 2022 | Hirschman Orin | 13G | 7.0% | 2.04M | SEC |
| 9 | Feb 1, 2022 | Bios Memory Spv I, LP | 13D/A | 6.5% | 1.42M | SEC |
| 10 | Oct 25, 2021 | Bios Memory Spv I, LP | 13D | 6.7% | 1.42M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bios Capital Management, LP | 6.00M | $4.56M |
| 2 | Davenport & Co LLC | 2.89M | $2.20M |
| 3 | Renaissance Technologies LLC | 1.12M | $848.5K |
| 4 | Chescapmanager LLC | 997.0K | $757.2K |
| 5 | Blackrock, Inc. | 968.4K | $735.5K |
| 6 | Geode Capital Management, LLC | 920.2K | $699.2K |
| 7 | Hilton Capital Management, LLC | 549.0K | $416.9K |
| 8 | Dauntless Investment Group, LLC | 431.0K | $327.3K |
| 9 | Cm Management, LLC | 400.0K | $303.8K |
| 10 | Jane Street Group, LLC | 370.1K | $281.1K |